Rituximab - Progress but Still Not a Final Resolution for Pemphigus Patients: Clinical Report From a Single Center Study

Pemphigus is a rare autoimmune disease characterized by the production of pathogenic autoantibodies against desmosomal adhesion proteins, desmoglein 1 and 3. The pathophysiological process leads to the development of blisters and erosions on mucosal and/or skin surfaces as the main clinical manifest...

Descripción completa

Detalles Bibliográficos
Autores principales: Miše, Joško, Jukić, Ines Lakoš, Marinović, Branka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110665/
https://www.ncbi.nlm.nih.gov/pubmed/35592312
http://dx.doi.org/10.3389/fimmu.2022.884931

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110665/
https://www.ncbi.nlm.nih.gov/pubmed/35592312
http://dx.doi.org/10.3389/fimmu.2022.884931

Ejemplares similares